Paysign (NASDAQ:PAYS) Stock: Insider Mark Newcomer Sells 50,000 Shares

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $15.34, for a total value of $767,000.00. Following the completion of the sale, the chief executive officer owned 9,113,002 shares in the company, valued at approximately $139,793,450.68. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Newcomer also recently made the following trade(s):

• On Thursday, August 6th, Mark Newcomer sold 150,000 shares of Paysign stock. The shares were sold at an average price of $11.88, for a total value of $1,782,000.00.
• On Wednesday, July 29th, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $9.38, for a total value of $469,000.00.

Paysign Stock Performance

Shares of PAYS stock opened at $15.60 on Friday. Paysign, Inc. has a 1 year low of $3.08 and a 1 year high of $15.63. The stock has a fifty day moving average of $13.41 and a two-hundred day moving average of $9.44. The firm has a market capitalization of $880.78 million, a PE ratio of 58.31 and a beta of 0.83.

Paysign (NASDAQ:PAYS) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.05. Paysign had a return on equity of 30.13% and a net margin of 15.67%. The company had revenue of $28.25 million during the quarter, compared to analysts’ expectations of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. Equities research analysts predict that Paysign, Inc. will post 0.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Paysign

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its position in shares of Paysign by 16.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 575,619 shares of the company’s stock valued at $3,396,000 after purchasing an additional 82,736 shares during the period. Bank of America Corp DE lifted its holdings in shares of Paysign by 345.9% in the first quarter. Bank of America Corp DE now owns 130,930 shares of the company’s stock valued at $772,000 after buying an additional 101,568 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Paysign by 17.4% in the first quarter. Renaissance Technologies LLC now owns 1,531,072 shares of the company’s stock valued at $9,033,000 after buying an additional 227,300 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in shares of Paysign in the second quarter valued at $877,000. Finally, BlackRock Inc. acquired a new stake in shares of Paysign in the second quarter valued at $25,219,000. 25.89% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PAYS. Lake Street Capital increased their target price on shares of Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, September 15th. Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Barrington Research set a $15.00 price target on shares of Paysign in a research report on Tuesday, August 11th. DA Davidson upped their price target on shares of Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, September 30th. Finally, Wall Street Zen cut shares of Paysign from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Three research analysts have rated the stock with a Buy rating. According to data from MarketBeat, Paysign currently has a consensus rating of “Buy” and a consensus target price of $15.00.

About Paysign

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.